Clinical TrialsRetatrutide Delivers Up to 28.3% Weight Loss and Improves Obesity-Related C... Retatrutide Delivers Up to 28.3% Weight Loss and Improves Obesity-Related C... Read Post »
Health TidingsStructure Reports Up to 16.2% Weight Loss With Oral GLP-1 Aleniglipron Structure Reports Up to 16.2% Weight Loss With Oral GLP-1 Aleniglipron Read Post »
Clinical TrialsAmneal Reports Positive Interim Result for CREXONT® in PD Amneal Reports Positive Interim Result for CREXONT® in PD Read Post »
Clinical TrialsNovo Nordisk Reports Strong Real-World Outcomes With Semaglutide 2 mg Escal... Novo Nordisk Reports Strong Real-World Outcomes With Semaglutide 2 mg Escal... Read Post »
Health TidingsVertex Reports Strong ALYFTREK Results in Young Children With Cystic Fibros... Vertex Reports Strong ALYFTREK Results in Young Children With Cystic Fibros... Read Post »
Health TidingsTeva Reports Quality-of-Life Benefits With AUSTEDO in HD Chorea Teva Reports Quality-of-Life Benefits With AUSTEDO in HD Chorea Read Post »
Clinical TrialsPfizer’s Berobenatide Delivers Up to 15.9% Weight Loss, Supports Broa... Pfizer’s Berobenatide Delivers Up to 15.9% Weight Loss, Supports Broa... Read Post »
Health TidingsSouth Africa Rolls Out Lenacapavir to Prevent HIV South Africa Rolls Out Lenacapavir to Prevent HIV Read Post »
Clinical TrialsAstraZeneca Reports Positive Phase III Results for Ultomiris in IgAN AstraZeneca Reports Positive Phase III Results for Ultomiris in IgAN Read Post »
Clinical TrialsMannKind Reports New Afrezza Findings Across Pediatric and Adult Diabetes P... MannKind Reports New Afrezza Findings Across Pediatric and Adult Diabetes P... Read Post »
Health TidingsNICE Endorses AbbVie’s Elahere as First New NHS Therapy in Over 20 Years ... NICE Endorses AbbVie’s Elahere as First New NHS Therapy in Over 20 Years ... Read Post »
Health TidingsMHRA Authorizes Aujemflu for Influenza Prevention in Adults 50+ MHRA Authorizes Aujemflu for Influenza Prevention in Adults 50+ Read Post »
Health TidingsADC Plans FDA Filing After Positive LOTIS-5 Results for ZYNLONTA ADC Plans FDA Filing After Positive LOTIS-5 Results for ZYNLONTA Read Post »
Clinical Trials Disease & DrugsInnovent’s Mazdutide Cuts BMI by Up to 11% in Adolescents with Obesity, A... Innovent’s Mazdutide Cuts BMI by Up to 11% in Adolescents with Obesity, A... Read Post »
Clinical TrialsNovo Nordisk’s Zenagamtide Lowers HbA1c by Up to 1.7% and Delivers 14.6% ... Novo Nordisk’s Zenagamtide Lowers HbA1c by Up to 1.7% and Delivers 14.6% ... Read Post »
Clinical TrialsBayer Reports Broad CKD Benefits with Finerenone in INFINITY Analysis Bayer Reports Broad CKD Benefits with Finerenone in INFINITY Analysis Read Post »
Health TidingsOtsuka Shows VOYXACT Slowed Kidney Function Decline in IgA Nephropathy Otsuka Shows VOYXACT Slowed Kidney Function Decline in IgA Nephropathy Read Post »
Health TidingsIV Ketamine Outperformed Esketamine in NRx’s Real-World Depression St... IV Ketamine Outperformed Esketamine in NRx’s Real-World Depression St... Read Post »
New Drug ApprovalNMPA Approves Lupeng’s Rocbrutinib, China’s First Fourth-Generation... NMPA Approves Lupeng’s Rocbrutinib, China’s First Fourth-Generation... Read Post »
ResearchNew EULAR Data Support CIMZIA Response Regardless of RF Status in RA New EULAR Data Support CIMZIA Response Regardless of RF Status in RA Read Post »
Clinical TrialsLundbeck’s PACAP Inhibitor Bocunebart Meets Endpoint in Migraine Lundbeck’s PACAP Inhibitor Bocunebart Meets Endpoint in Migraine Read Post »
Clinical TrialsBayer’s Finerenone Delivers Positive Phase III Results in Non-Diabeti... Bayer’s Finerenone Delivers Positive Phase III Results in Non-Diabeti... Read Post »
GenericsLupin and Alembic Secure FDA Approvals, Expanding Indian Pharma’s U.S. Fo... Lupin and Alembic Secure FDA Approvals, Expanding Indian Pharma’s U.S. Fo... Read Post »
Health TidingsFDA Issues Complete Response Letter for Xspray’s Nilopki NDA FDA Issues Complete Response Letter for Xspray’s Nilopki NDA Read Post »
New Drug ApprovalMHRA Approves First MASH Treatment for Patients With Liver Fibrosis MHRA Approves First MASH Treatment for Patients With Liver Fibrosis Read Post »
Clinical TrialsCosentyx Improves Long-Term Disease Control in Polymyalgia Rheumatica Cosentyx Improves Long-Term Disease Control in Polymyalgia Rheumatica Read Post »
Clinical TrialsAutobahn Posts Positive Data for Elunetirom in Bipolar Depression Autobahn Posts Positive Data for Elunetirom in Bipolar Depression Read Post »
GenericsTeva Enters Ophthalmology With European Launch of AHZANTIVE Teva Enters Ophthalmology With European Launch of AHZANTIVE Read Post »
Mergers & AcquisitionsAlnylam Partners With Inceptive in Up to $2 Billion AI Drug Discovery Deal Alnylam Partners With Inceptive in Up to $2 Billion AI Drug Discovery Deal Read Post »
Health TidingsUCB and Biogen Present New Phase 3 Dapirolizumab Pegol Results in SLE UCB and Biogen Present New Phase 3 Dapirolizumab Pegol Results in SLE Read Post »
Health TidingsFDA Grants Breakthrough Therapy Designation to Biogen’s Salanersen for SM... FDA Grants Breakthrough Therapy Designation to Biogen’s Salanersen for SM... Read Post »
Clinical TrialsInnovent Files China NDA for Arcotatug Tavatecan in Advanced Gastric Cancer Innovent Files China NDA for Arcotatug Tavatecan in Advanced Gastric Cancer Read Post »
Clinical TrialsNovartis Reports Positive Final Phase III Results for Vanrafia in IgA Nephr... Novartis Reports Positive Final Phase III Results for Vanrafia in IgA Nephr... Read Post »
Clinical TrialsImmutep Reports Positive Phase I Results for IMP761 in Autoimmune Disease Immutep Reports Positive Phase I Results for IMP761 in Autoimmune Disease Read Post »
Health TidingsFDA Accepts Pharming’s Pediatric sNDA for Joenja® in APDS FDA Accepts Pharming’s Pediatric sNDA for Joenja® in APDS Read Post »
Health TidingsTerremoto Advances TER-2013 With FDA Fast Track Designation Terremoto Advances TER-2013 With FDA Fast Track Designation Read Post »
Health TidingsCingulate’s ADHD Drug CTx-1301 Hit with FDA Complete Response Letter Cingulate’s ADHD Drug CTx-1301 Hit with FDA Complete Response Letter Read Post »
GenericsApotex Launches Lower-Cost Sitagliptin Therapies for Type 2 Diabetes Apotex Launches Lower-Cost Sitagliptin Therapies for Type 2 Diabetes Read Post »
Health Tidings Mergers & AcquisitionsIDEAYA and Roche Advance PRMT5 and Pan-RAS Inhibitors in Pancreatic Cancer IDEAYA and Roche Advance PRMT5 and Pan-RAS Inhibitors in Pancreatic Cancer Read Post »
Clinical TrialsJohnson & Johnson Reports Positive Phase 2 Lupus Data for Nipocalimab Johnson & Johnson Reports Positive Phase 2 Lupus Data for Nipocalimab Read Post »
Health Tidings Mergers & AcquisitionsAscidian Secures Up to $1.9 Billion in Lilly Kidney Disease Partnership Ascidian Secures Up to $1.9 Billion in Lilly Kidney Disease Partnership Read Post »
Health TidingsKura Reports Early Success for Darlifarnib in KRAS-Mutant Solid Tumors Kura Reports Early Success for Darlifarnib in KRAS-Mutant Solid Tumors Read Post »
Health TidingsKyverna Reports Sustained Clinical Benefit With miv-cel in Refractory RA Kyverna Reports Sustained Clinical Benefit With miv-cel in Refractory RA Read Post »
Clinical Trialsargenx Shows Durable Efgartigimod Benefits in Myositis and Sjögren’s Dis... argenx Shows Durable Efgartigimod Benefits in Myositis and Sjögren’s Dis... Read Post »
Clinical TrialsTenaya’s TN-201 Shows Durable Benefits in MYBPC3-Associated HCM Tenaya’s TN-201 Shows Durable Benefits in MYBPC3-Associated HCM Read Post »
Health Tidings Mergers & AcquisitionsCytomX Secures Expanded Regeneron Partnership Worth Up to $4 Billion CytomX Secures Expanded Regeneron Partnership Worth Up to $4 Billion Read Post »
Clinical TrialsUCB Shows Long-Term Benefits of BIMZELX in PsA and axSpA UCB Shows Long-Term Benefits of BIMZELX in PsA and axSpA Read Post »
GenericsLupin and Natco Secure FDA Approval for Eribulin Mesylate Injection Lupin and Natco Secure FDA Approval for Eribulin Mesylate Injection Read Post »
Health TidingsMannKind Advances Inhaled Nintedanib into Phase 2 Trial for IPF MannKind Advances Inhaled Nintedanib into Phase 2 Trial for IPF Read Post »
Clinical TrialsTakeda, Innovent Advance IBI363 With Strong Survival Data in Resistant NSCL... Takeda, Innovent Advance IBI363 With Strong Survival Data in Resistant NSCL... Read Post »
